Melissa Cochran is a nurse practitioner in the Adult Stem Cell Transplant Program at Dana-Farber Cancer Institute. She completed her nursing degrees from Columbia University in 2000. Prior to Dana-Farber, she worked as an inpatient oncology RN and NP at Mount Sinai Medical Center in NY and Westchester Medical Center in Valhalla, NY. She has been at DFCI with the transplant group for 12 years. In this role, she provides team approached to care for outpatient bone marrow transplant patients managing complications such as infections, acute and chronic graft versus host disease, symptom management, and extensive patient education. She volunteers with ASBMT as a member of their Committee on Education. Their mission is to provide transplant specific educational opportunities for all members of ASBMT. She is currently co-chairing the clinical education conference for NPs/PAs and fellows at the Tandem Meetings.

Jason Glass, ACNP-BC

Jason Glass, ACNP-BC has been an oncology nurse for 12 years, the last 7 spent in the Head and Neck group at the Dana-Farber Cancer Institute. His primary role is getting patients safely through their rigorous treatment's maximizing comfort and minimizing side effects and delays. A graduate of the MGH Institute of Health Professions, Jason has also been a preceptor and adjunct faculty member. He is a past Treasurer for the Boston chapter of the Oncology Nursing Society. At the end of the day, Jason looks forward to coming home to his wife Brooke and their three wonderful children. In his spare time, Jason relaxes by rebuilding classic arcade machines from the 1980's.

Conflict of Interest Disclosure: Dr. Jason Glass receives financial compensation as part of his role on a nursing advisory board for Merck related to immuno-oncology. 

Glenn Hanna, MD

Dr. Hanna completed his residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in hematology & medical oncology at the Dana-Farber Cancer Institute in 2016. Prior to this, he earned his medical degree from Georgetown University School of Medicine in 2010, where he graduated summa cum laude, a member of Alpha Omega Alpha Honor Society and the Kober Medalist for academic excellence. Dr. Hanna also graduated summa cum laude from the University of Florida and is originally from the south Florida area. He joined the faculty of the Center for Head & Neck Oncology in 2017.

Jason Kass, Md/ PhD

Dr. Jason Kass, M.D., Ph.D. is a Head and Neck Surgeon at the Brigham and Women's Hospital and Dana-Farber Cancer Institute.  Dr. Kass completed his MD/ Ph.D. at the Boston University School of Medicine in Anatomy and Neurobiology.  His residency training in Head and Neck Surgery was completed at the University of Pittsburgh Medical Center (UPMC).  He then completed fellowship training in Advanced Head and Neck Oncology and Microvascular Reconstruction at the ICahn School of Medicine at Mount Sinai, New York, NY.  His clinical expertise is in the multidisciplinary management of head and neck cancers, including transoral robotic surgery (TORS), and microvascular reconstruction using free tissue transfer.  Dr. Kass has clinical research interests in the functional outcomes following robotic-assisted surgery as well as novel non-invasive imaging technologies to monitor blood flow following microvascular surgery.

Lauren Patton, DDS

Dr. Patton is Professor and Chair Department of Dental Ecology at the UNC School of Dentistry and Director of the GPR program. Current President-Elect of the AAOM, she is a Diplomate and past President of the ABOM. She is also a Diplomate of the American Board of Special Care Dentistry. She earned her DDS at UNC and attended the 2-year UNC GPR and the 2-year NIDCR Clinical Dental Staff Fellowship for her Oral Medicine/Research training.

She has conducted industry and federal governments' funded clinical and health services research; participated in teaching at dental hygiene, dental, and post-doctoral levels; published over 140 papers, monographs, and book chapters; and lectured internationally on oral manifestations and management of patients with medical complexities, such as HIV/AIDS and oral cancer. She is the Oral Medicine Section Editor of Oral Surg Oral Med Oral Pathol Oral Radiol and serves on the ADA Council on Scientific Affairs.

Andres Pinto, DMD, MPH, MSCE, MBA

Dr. Pinto is Chairman and Professor of Oral and Maxillofacial Medicine in the Department of Oral and Maxillofacial Medicine and Diagnostic Sciences. He is also an attending physician in the Department of Surgery, Divisions of Oral and Maxillofacial Surgery and Pediatric Dentistry at University Hospitals Cleveland Medical Center and Rainbow Babies and Children’s Hospital, and a consultant in the VA system. He received his DMD, MPH, MSCE, certificate in Clinical Research, and certificate in Oral Medicine from the University of Pennsylvania, School of Dental Medicine and School of Medicine, a certificate in Dental Public Health from the National Institutes of Health, and an MBA in healthcare administration from the Weatherhead School of Management.

Katherine Reinshagen

Dr. Reinshagen is a radiologist at the Massachusetts Eye and Ear, and Instructor in Radiology at Harvard Medical School.

Vidya Sankar, DMD, MHS

Dr. Sankar received her DMD from the University of Medicine and Dentistry of New Jersey in 1994. She did a one year General Practice Residency from 1994-1995 and became Staff Dentist in the Infectious Disease Clinic at UMDNJ from 1995-1996. After a few years of private practice, Dr. Sankar earned her Certificate in Oral Medicine from the National Institutes of Health (NIH)/ National Institute of Dental and Craniofacial Research (NIDCR), Bethesda, Maryland in 2001. She is certified by the American Board of Oral Medicine. During her 6 years at NIDCR, she was a recipient of the Sjögren’s Syndrome Foundation Fellowship, was involved with several clinical trials and investigations at the Sjögren’s Syndrome Clinic. She received her Masters in Health Science degree from Duke University in 2001. Dr. Sankar is currently the Clinic Director of the Oral Medicine and Dentistry Clinic at Brigham and Women’s Hospital and Co-Director of the Oral Medicine and Oncology Clinic at Dana-Farber Cancer Institute. She has professional affiliations with the American Academy of Oral Medicine, the American Board of Oral Medicine, and the American Dental Association.

Stephen Sonis, DMD, DMSc

Stephen T. Sonis, DMD, DMSc Dr. Sonis is a Professor of Oral Medicine at Harvard, Senior Surgeon at Brigham and Women’s Hospital and a designated member of the Distinguished Faculty at the Dana-Farber Cancer Institute. In addition to his academic appointments, Dr. Sonis is a co-founder and Chief Scientific Officer (CSO) of Biomodels, LLC and Primary Endpoint Solutions, LLC; Past president of TRIAD, an international not-for-profit focused on the adverse health and economic outcomes of cancer toxicities; and a special government employee of the FDA. He has published extensively on the clinical, biological, and health economic aspects of cancer and complications associated with its treatment. He holds several patents and is the author of more than 250 original publications, reviews, and chapters and is completing his eleventh book. After receiving his DMD from Tufts, Dr. Sonis completed a combined doctorate and residency at Harvard and was a Knox Fellow at Oxford.

Herve Sroussi

Dr. Herve Sroussi is the Director for Research of the Division of Oral Medicine and Dentistry at Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute.Dr. Herve Sroussi is the Director for Research of the Division of Oral Medicine and Dentistry at Brigham and Women's Hospital (BWH) and Dana-Farber Cancer Institute.

Dr. Sroussi earned his dental degree from The Hebrew University-Hadassah School of Dental Medicine in 1994. He completed an oral medicine residency at the University of California, San Francisco, School of Dentistry (UCSF) and is board certified in oral medicine. Dr. Sroussi also completed a Ph.D. in Oral Sciences in the field of mucosal immunology and virology at UCSF. Before joining Brigham and Women's, he was an Associate Professor with tenure and Director of the Oral Medicine Clinic at the University of Illinois College of Dentistry in Chicago Illinois.

Dr. Sroussi's research is primarily focused in the field of oral mucosal infection and immunity with an emphasis on innate immunology and immune suppression.

Eric Stoopler, DMD, FDSRCS, FDSRCPS

Dr. Eric Stoopler is a Professor of Oral Medicine at the University of Pennsylvania (Penn) School of Dental Medicine. He completed his undergraduate studies at S.U.N.Y Binghamton in 1994 and earned his DMD from Penn in 1999. Dr. Stoopler completed a General Practice Residency at the Brooklyn VA Hospital in 2000 and a Fellowship in Oral Medicine at Penn in 2002. Dr. Stoopler holds Fellowship in The American Association of Hospital Dentists, The International College of Dentists, The Royal College of Surgeons (Ed, Eng), The Royal College of Physicians and Surgeons (Glasg) and is a Diplomate of The American Board of Oral Medicine and The American Board of Special Care Dentistry. Currently, he maintains an active clinical oral medicine practice at the University of Pennsylvania Health System and is a Consultant to the Children's Hospital of Philadelphia.

Roy Tishler, Director, Head and Neck Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital

Dr. Tishler is Director of Head and Neck Radiation Oncology at the DFCI/BWH.  He received MD, Ph.D. degrees from Johns Hopkins. His research interests include combined modality therapy for HN cancers, outcomes in HN with IMRT treatment and patient safety.

Conflict of Interest Disclosure: Dr. Tishler is on a Data Safety Monitoring Board for a clinical trial sponsored by Oragenics; the activity is organized by a contract research organization (CRO) called PSI.

Nathaniel Treister, DMD, DMSc

Dr. Treister is Chief of the Divisions of Oral Medicine and Dentistry at Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, Massachusetts. Dr. Treister earned his DMD from the University of Pennsylvania School of Dental Medicine and subsequently completed his Oral Medicine certificate and Oral Biology doctoral training at the Harvard School of Dental Medicine, where he is an Associate Professor of Oral Medicine in the Department of Oral Medicine, Infection and Immunity. He is board certified in Oral Medicine and practices at Brigham and Women's Hospital and Dana-Farber Cancer Institute with a special interest in oral mucosal diseases, salivary gland diseases, and oral complications in cancer patients. He has published extensively in the field of oral medicine with an emphasis on oral complications of hematopoietic cell transplantation and chronic graft-versus-host disease.

Alessandro Villa, DDS, PhD, MPH

Dr. Alessandro Villa is an Associate Surgeon in the Division of Oral Medicine and Dentistry at Brigham and Women's Hospital and an Assistant Professor at Harvard School of Dental Medicine where he also serves as the Program Director of the Oral Medicine Residency. Dr. Villa obtained his DDS degree and a Ph.D. from Italy. He served as a post-doctoral fellow at the National Cancer Institute, obtained his Master of Public Health from AT Still University, MO and his Certificate in Oral Medicine from Harvard School of Dental Medicine. Dr. Villa's research interests are focused primarily on oral potentially malignant disorders and oral HPV prevention. His clinical interest includes treatment of oral mucosal diseases, pre-cancerous lesions, salivary gland disorders and oral complications from cancer therapy. Dr. Villa teaches in the clinic as well as in class.

Sook-Bin Woo, Associate Professor

Dr. Woo is a board-certified oral pathologist and oral medicine specialist, and program director for the graduate oral pathology training program at the Harvard School of Dental Medicine. She received her training in oral pathology at Indiana University School of Dentistry, and head and neck pathology at Long Island Jewish Medical Center, New York. Her dual certification puts her in a unique position to correlate the clinical findings of oral mucosal disease with their histopathologic features which is essential in understanding mucosal disease and in particular, precancerous conditions such as leukoplakia. Her other interests include adverse drug reactions that present in the oral cavity such as medication-associated osteonecrosis of the jaw, as well as human papillomavirus infection in oral dysplasia. She is recipient of the Distinguished Senior Faculty Award from the Harvard School of Dental Medicine.